Clot-busting drug alteplase shows promise for stroke treatment up to 24 hours after onset

The clot-dissolving medication, alteplase, improved stroke patients’ recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary late-breaking science presented today at the American Stroke Association’s International Stroke Conference 2025.

Trump picks RFK Jr. for HHS; AbbVie’s psych implosion; Merck tries staving off Summit; and more

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 17, 2024

Virtual Second Opinions on the Rise: Cardiology, Cancer, and Neurology Lead the Way

What You Should Know: – A new study by The Clinic by Cleveland Clinic has shed light on the increasing demand for virtual second opinions

September 17, 2024

New insights into uncontrollable movements in Parkinson’s disease patients

University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson’s disease patients: uncontrollable movements that develop after

January 3, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.